Agency Forms Undergoing Paperwork Reduction Act Review, 29451-29453 [2020-10409]
Download as PDF
<![CDATA[
29451
Federal Register / Vol. 85, No. 95 / Friday, May 15, 2020 / Notices
2. Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and
clarity of the information to be
collected; and
4. Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submissions
of responses.
5. Assess information collection costs.
Proposed Project
Emerging Infections Program Tracking
of SARS–CoV–2 Infections among
Healthcare Personnel—New—National
Center for Emerging and Zoonotic
Infectious Diseases (NCEZID), Centers
for Disease Control and Prevention
(CDC).
Background and Brief Description
CDC proposes to conduct tracking and
interviews of healthcare personnel
(HCP) with COVID–19 (HCP cases) and
HCP exposed to COVID–19 patients but
who do not become cases (HCP noncases) to determine the burden of
infections and identify factors
associated with development of COVID–
19 among HCP of healthcare facilities
within catchment areas of CDC’s
Emerging Infection Program’s (EIP) sites,
a network of 10 state health departments
and their local public health and
academic partners. The EIP is currently
approved under OMB Control No. 0920–
0978 (expiration date: 04/30/2022). EIPs
assist in local, state, and national efforts
to prevent, control, and monitor the
public health impact of infectious
diseases. The 10 EIP sites are:
California, Colorado, Connecticut,
Georgia, Maryland, Minnesota, New
Mexico, New York, Oregon and
Tennessee. Up to 10 EIP sites may
participate in this information
collection, depending on resource
availability during the pandemic.
EIP sites that participate in this
project may choose to implement one or
both project options below:
• Option 1: Tracking of SARS–CoV–
2 infections among HCP;
• Option 2: Assessing risk factors for
infections among HCP exposed to
patients with COVID–19 in healthcare
facilities.
EIP site staff will identify a
convenience sample of healthcare
facilities within the EIP catchment
areas. Hospitals and nursing homes are
prioritized for inclusion, but other types
Number of
respondents
Estimated Annualized Burden Hours
Average
burden per
response
(in hours)
Number of
responses per
respondent
Total burden
(in hours)
Type of respondents
Form name
Healthcare Personnel .......................
4,000
1
30/60
2,000
at
Assessment of Healthcare Personnel.
Exposed to or Infected with SARS–
CoV–2.
No form .............................................
50
24
15/60
300
Total ...........................................
...........................................................
........................
........................
........................
2,300
Occupational Health Nurses
Healthcare Facilities.
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
[FR Doc. 2020–10410 Filed 5–14–20; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day–20–20HP]
Agency Forms Undergoing Paperwork
Reduction Act Review
jbell on DSKJLSW7X2PROD with NOTICES
of facilities may participate. Each EIP
site will seek to identify three or more
facilities to participate.
For option 1, EIP staff will obtain lists
of HCP cases and contact information
from local or state health department
partners or in some cases from a
healthcare facility’s occupational health
department or infection control
program. To minimize burden on
healthcare facilities, EIP staff will
attempt to obtain HCP lists and contact
information from health departments
whenever possible.
For option 2, EIP staff may need to
work directly with a healthcare facility’s
occupational health department or
infection control program to obtain HCP
names and contact information because
this option requires identification and
data collection from HCP non-cases
(HCP who are exposed to COVID–19
patients but who do not develop
infection).
For both options, EIP staff will collect
data from HCP via telephone interviews
or a self-administered electronic case
report form. There are no costs to
respondents other than their time to
participate. The total estimated
annualized burden hours requested for
this collection is 2,300.
In accordance with the Paperwork
Reduction Act of 1995, the Centers for
Disease Control and Prevention (CDC)
has submitted the information
collection request titled National
Evaluation of the DP18–1815
Cooperative Agreement Program:
Category B, Cardiovascular Disease
Prevention and Management to the
VerDate Sep<11>2014
17:09 May 14, 2020
Jkt 250001
PO 00000
Frm 00060
Fmt 4703
Sfmt 4703
Office of Management and Budget
(OMB) for review and approval. CDC
previously published a ‘‘Proposed Data
Collection Submitted for Public
Comment and Recommendations’’
notice on July 5, 2019, to obtain
comments from the public and affected
agencies. CDC did not receive comments
related to the previous notice. This
notice serves to allow an additional 30
days for public and affected agency
comments.
CDC will accept all comments for this
proposed information collection project.
The Office of Management and Budget
is particularly interested in comments
that:
(a) Evaluate whether the proposed
collection of information is necessary
E:\FR\FM\15MYN1.SGM
15MYN1
29452
Federal Register / Vol. 85, No. 95 / Friday, May 15, 2020 / Notices
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
(b) Evaluate the accuracy of the
agencies estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and
clarity of the information to be
collected;
(d) Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses; and
(e) Assess information collection
costs.
To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
instruments, call (404) 639–7570.
Comments and recommendations for the
proposed information collection should
be sent within 30 days of publication of
this notice to www.reginfo.gov/public/
do/PRAMain. Find this particular
information collection by selecting
‘‘Currently under 30-day Review—Open
for Public Comments’’ or by using the
search function. Direct written
comments and/or suggestions regarding
the items contained in this notice to the
Attention: CDC Desk Officer, Office of
Management and Budget, 725 17th
Street NW, Washington, DC 20503 or by
fax to (202) 395–5806. Provide written
comments within 30 days of notice
publication.
Proposed Project
National Evaluation of the DP18–1815
Cooperative Agreement Program:
Category B, Cardiovascular Disease
Prevention and Management—New—
National Center for Chronic Disease
Prevention and Health Promotion
(NCCDPHP), Centers for Disease Control
and Prevention (CDC).
Background and Brief Description
The Centers for Disease Control and
Prevention (CDC) plans to conduct a
comprehensive evaluation of the
recently launched five-year Cooperative
Agreement program CDC–RFA–DP18–
1815PPHF18: Improving the Health of
Americans Through Prevention and
Management of Diabetes and Heart
Disease and Stroke, hereafter referred to
as ‘‘1815’’. This cooperative agreement
funds all 50 State Health Departments
and the Washington, DC health
department (hereafter referred to as ‘‘HD
recipients’’) to support investments in
implementing evidence-based strategies
to prevent and manage cardiovascular
disease (CVD) and diabetes in highburden populations/communities
within each state and the District of
Columbia. High burden populations/
communities are those affected
disproportionately by high blood
pressure, high blood cholesterol,
diabetes, or prediabetes due to
socioeconomic or other characteristics,
including access to care, poor quality of
care, or low income. The 1815 program
is a collaboration between the Division
of Diabetes Translation (DDT) and the
Division of Heart Disease and Stroke
Prevention (DHDSP), and is structured
into two program categories aligning
with each Division.
This information collection request
focuses on activities conducted under
Category B, Cardiovascular Disease
Prevention and Management. Progress
will be assessed for three CVD program
areas: (1) Tracking and monitoring
clinical quality measures (CQM) shown
to improve healthcare quality and
identify patients with hypertension; (2)
Implementing team-based care and
medication therapy management (TBC/
MTM) for patients with high blood
pressure and high blood cholesterol;
and (3) Fostering community-clinical
linkages (CCL) for community resources
and clinical services that support
systematic referrals, self-management,
and lifestyle change for patients with
high blood pressure and high blood
cholesterol.
This cooperative agreement is a
substantial investment of federal funds.
DDT and DHDSP are responsible for the
stewardship of these funds, and they
must be able to demonstrate the types of
interventions being implemented and
what is being accomplished through the
use of these funds. Thus, throughout the
five-year cooperative agreement period,
CDC will work with HD recipients to
track the implementation of the
cooperative agreement strategies and
evaluate program processes and
outcomes. In order to collect this
information for Category B, CDC has
designed three overarching components:
(1) Category B case studies, (2) Category
B cost study, and (3) Category B
recipient-led evaluations. Each
component consists of data collection
mechanisms and tools that are designed
to capture the most relevant information
needed to inform the evaluation effort
while placing minimum burden on
respondents. Respondents will include
HD recipients, as well as select HD
recipient partner sites, which are
organizations that HD recipients are
partnering with in the implementation
of the 1815 strategies.
The evaluation of cooperative
agreement strategies and activities
conducted by DHDSP will determine
the efficiency, effectiveness, impact and
sustainability of 1815-funded strategies
in the promotion, prevention, and
management of diabetes and heart
disease and help identify promising
practices that can be replicated and
scaled to better improve health
outcomes. In addition, evaluation plays
a critical role in organizational learning,
program planning, decision-making, and
measurement of the 1815 strategies. As
an action-oriented process, the
evaluation will serve to identify
programs that have positive outcomes,
identify those that may need additional
technical assistance support, and
highlight the specific activities that
make the biggest contribution to
improving diabetes and cardiovascular
disease prevention and management
efforts. Without collection of new
evaluative data, CDC will not be able to
capture critical information needed to
continuously improve programmatic
efforts and clearly demonstrate the use
of federal funds.
OMB approval is requested for three
years. Participation is required for
cooperative agreement awardees and
voluntary for partner sites. The total
estimated annualized burden hours are
743.
jbell on DSKJLSW7X2PROD with NOTICES
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Type of respondent
Form name
Health Department (1815 Recipient) ..............
CQM Health Department Interview Guide .....
CQM Group Discussion Guide .......................
TBC Health Department Interview Guide ......
VerDate Sep<11>2014
17:09 May 14, 2020
Jkt 250001
PO 00000
Frm 00061
Fmt 4703
Sfmt 4703
E:\FR\FM\15MYN1.SGM
Number of
responses per
respondent
17
27
9
15MYN1
1
1
1
Average
burden per
response
(in hours)
1.5
2
1.5
29453
Federal Register / Vol. 85, No. 95 / Friday, May 15, 2020 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS—Continued
Type of respondent
Partner/Site-Level ...........................................
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
MTM Health Department Interview Guide .....
TBC Group Discussion Guide ........................
CCL Health Department Interview Guide ......
CCL Group Discussion Guide ........................
Cost Study Resource Use and Cost Study
Inventory Tool—Health Department.
Recipient-Led Evaluation Annual Report
Template—Year 3 Effectiveness Brief.
CQM Partner Site-Level Interview Guide .......
TBC Partner Site-Level Interview Guide ........
MTM Partner Site-Level Interview Guide .......
CCL Partner Site-Level Informant Interview
Guide.
Cost Study Resource Use and Cost Inventory Tool—Partner/Site Level.
[60Day-20–20NE; Docket No. CDC–2020–
0045]
You may submit comments,
identified by Docket No. CDC–2020–
0045 by any of the following methods:
• Federal eRulemaking Portal:
Regulations.gov. Follow the instructions
for submitting comments.
• Mail: Jeffrey M. Zirger, Information
Collection Review Office, Centers for
Disease Control and Prevention, 1600
Clifton Road NE, MS–D74, Atlanta,
Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. CDC will post, without
change, all relevant comments to
Regulations.gov.
Proposed Data Collection Submitted
for Public Comment and
Recommendations
Please note: Submit all comments through
the Federal eRulemaking portal
(regulations.gov) or by U.S. mail to the
address listed above.
[FR Doc. 2020–10409 Filed 5–14–20; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
AGENCY:
ACTION:
Notice with comment period.
The Centers for Disease
Control and Prevention (CDC), as part of
its continuing effort to reduce public
burden and maximize the utility of
government information, invites the
general public and other Federal
agencies the opportunity to comment on
a proposed and/or continuing
information collection, as required by
the Paperwork Reduction Act of 1995.
This notice invites comment on a
proposed information collection project
titled Infant Feeding Practices Study III
to understand the current state of
mothers’ intentions, behaviors, feeding
decisions, and practices from pregnancy
through their child’s first two years of
life and how these change.
SUMMARY:
jbell on DSKJLSW7X2PROD with NOTICES
Number of
respondents
Form name
CDC must receive written
comments on or before July 14, 2020.
DATES:
VerDate Sep<11>2014
17:09 May 14, 2020
Jkt 250001
ADDRESSES:
To
request more information on the
proposed project or to obtain a copy of
the information collection plan and
instruments, contact Jeffrey M. Zirger,
Information Collection Review Office,
Centers for Disease Control and
Prevention, 1600 Clifton Road NE, MS–
D74, Atlanta, Georgia 30329; phone:
404–639–7118; Email: omb@cdc.gov.
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), Federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. In addition, the PRA also
requires Federal agencies to provide a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each new
proposed collection, each proposed
extension of existing collection of
information, and each reinstatement of
previously approved information
collection before submitting the
FOR FURTHER INFORMATION CONTACT:
PO 00000
Frm 00062
Fmt 4703
Sfmt 4703
Number of
responses per
respondent
Average
burden per
response
(in hours)
8
27
17
27
8
1
1
1
1
1
1.5
2
1.5
2
2
51
1
8
15
8
7
15
1
1
1
1
1
1
1
1
17
1
2
collection to the OMB for approval. To
comply with this requirement, we are
publishing this notice of a proposed
data collection as described below.
The OMB is particularly interested in
comments that will help:
1. Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
2. Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and
clarity of the information to be
collected; and
4. Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submissions
of responses.
5. Assess information collection costs.
Proposed Project
Infant Feeding Practices Study III–
New–National Center for Chronic
Disease Prevention and Health
Promotion (NCCDPHP), Centers for
Disease Control and Prevention (CDC).
Background and Brief Description
Infant Feeding Practices Study (IFPS)
III is a longitudinal study that will
follow pregnant women and their new
baby for two years. Data will be
collected using web-based surveys at
multiple time points over two years.
This includes (1) a prenatal survey, (2)
14 follow up surveys after the baby is
E:\FR\FM\15MYN1.SGM
15MYN1
]]>Agencies
[Federal Register Volume 85, Number 95 (Friday, May 15, 2020)]
[Notices]
[Pages 29451-29453]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-10409]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30Day-20-20HP]
Agency Forms Undergoing Paperwork Reduction Act Review
In accordance with the Paperwork Reduction Act of 1995, the Centers
for Disease Control and Prevention (CDC) has submitted the information
collection request titled National Evaluation of the DP18-1815
Cooperative Agreement Program: Category B, Cardiovascular Disease
Prevention and Management to the Office of Management and Budget (OMB)
for review and approval. CDC previously published a ``Proposed Data
Collection Submitted for Public Comment and Recommendations'' notice on
July 5, 2019, to obtain comments from the public and affected agencies.
CDC did not receive comments related to the previous notice. This
notice serves to allow an additional 30 days for public and affected
agency comments.
CDC will accept all comments for this proposed information
collection project. The Office of Management and Budget is particularly
interested in comments that:
(a) Evaluate whether the proposed collection of information is
necessary
[[Page 29452]]
for the proper performance of the functions of the agency, including
whether the information will have practical utility;
(b) Evaluate the accuracy of the agencies estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and clarity of the information to
be collected;
(d) Minimize the burden of the collection of information on those
who are to respond, including through the use of appropriate automated,
electronic, mechanical, or other technological collection techniques or
other forms of information technology, e.g., permitting electronic
submission of responses; and
(e) Assess information collection costs.
To request additional information on the proposed project or to
obtain a copy of the information collection plan and instruments, call
(404) 639-7570. Comments and recommendations for the proposed
information collection should be sent within 30 days of publication of
this notice to www.reginfo.gov/public/do/PRAMain. Find this particular
information collection by selecting ``Currently under 30-day Review--
Open for Public Comments'' or by using the search function. Direct
written comments and/or suggestions regarding the items contained in
this notice to the Attention: CDC Desk Officer, Office of Management
and Budget, 725 17th Street NW, Washington, DC 20503 or by fax to (202)
395-5806. Provide written comments within 30 days of notice
publication.
Proposed Project
National Evaluation of the DP18-1815 Cooperative Agreement Program:
Category B, Cardiovascular Disease Prevention and Management--New--
National Center for Chronic Disease Prevention and Health Promotion
(NCCDPHP), Centers for Disease Control and Prevention (CDC).
Background and Brief Description
The Centers for Disease Control and Prevention (CDC) plans to
conduct a comprehensive evaluation of the recently launched five-year
Cooperative Agreement program CDC-RFA-DP18-1815PPHF18: Improving the
Health of Americans Through Prevention and Management of Diabetes and
Heart Disease and Stroke, hereafter referred to as ``1815''. This
cooperative agreement funds all 50 State Health Departments and the
Washington, DC health department (hereafter referred to as ``HD
recipients'') to support investments in implementing evidence-based
strategies to prevent and manage cardiovascular disease (CVD) and
diabetes in high-burden populations/communities within each state and
the District of Columbia. High burden populations/communities are those
affected disproportionately by high blood pressure, high blood
cholesterol, diabetes, or prediabetes due to socioeconomic or other
characteristics, including access to care, poor quality of care, or low
income. The 1815 program is a collaboration between the Division of
Diabetes Translation (DDT) and the Division of Heart Disease and Stroke
Prevention (DHDSP), and is structured into two program categories
aligning with each Division.
This information collection request focuses on activities conducted
under Category B, Cardiovascular Disease Prevention and Management.
Progress will be assessed for three CVD program areas: (1) Tracking and
monitoring clinical quality measures (CQM) shown to improve healthcare
quality and identify patients with hypertension; (2) Implementing team-
based care and medication therapy management (TBC/MTM) for patients
with high blood pressure and high blood cholesterol; and (3) Fostering
community-clinical linkages (CCL) for community resources and clinical
services that support systematic referrals, self-management, and
lifestyle change for patients with high blood pressure and high blood
cholesterol.
This cooperative agreement is a substantial investment of federal
funds. DDT and DHDSP are responsible for the stewardship of these
funds, and they must be able to demonstrate the types of interventions
being implemented and what is being accomplished through the use of
these funds. Thus, throughout the five-year cooperative agreement
period, CDC will work with HD recipients to track the implementation of
the cooperative agreement strategies and evaluate program processes and
outcomes. In order to collect this information for Category B, CDC has
designed three overarching components: (1) Category B case studies, (2)
Category B cost study, and (3) Category B recipient-led evaluations.
Each component consists of data collection mechanisms and tools that
are designed to capture the most relevant information needed to inform
the evaluation effort while placing minimum burden on respondents.
Respondents will include HD recipients, as well as select HD recipient
partner sites, which are organizations that HD recipients are
partnering with in the implementation of the 1815 strategies.
The evaluation of cooperative agreement strategies and activities
conducted by DHDSP will determine the efficiency, effectiveness, impact
and sustainability of 1815-funded strategies in the promotion,
prevention, and management of diabetes and heart disease and help
identify promising practices that can be replicated and scaled to
better improve health outcomes. In addition, evaluation plays a
critical role in organizational learning, program planning, decision-
making, and measurement of the 1815 strategies. As an action-oriented
process, the evaluation will serve to identify programs that have
positive outcomes, identify those that may need additional technical
assistance support, and highlight the specific activities that make the
biggest contribution to improving diabetes and cardiovascular disease
prevention and management efforts. Without collection of new evaluative
data, CDC will not be able to capture critical information needed to
continuously improve programmatic efforts and clearly demonstrate the
use of federal funds.
OMB approval is requested for three years. Participation is
required for cooperative agreement awardees and voluntary for partner
sites. The total estimated annualized burden hours are 743.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Average
Number of Number of burden per
Type of respondent Form name respondents responses per response (in
respondent hours)
----------------------------------------------------------------------------------------------------------------
Health Department (1815 Recipient).... CQM Health Department 17 1 1.5
Interview Guide.
CQM Group Discussion 27 1 2
Guide.
TBC Health Department 9 1 1.5
Interview Guide.
[[Page 29453]]
MTM Health Department 8 1 1.5
Interview Guide.
TBC Group Discussion 27 1 2
Guide.
CCL Health Department 17 1 1.5
Interview Guide.
CCL Group Discussion 27 1 2
Guide.
Cost Study Resource Use 8 1 2
and Cost Study
Inventory Tool--Health
Department.
Recipient-Led Evaluation 51 1 8
Annual Report Template--
Year 3 Effectiveness
Brief.
Partner/Site-Level.................... CQM Partner Site-Level 15 1 1
Interview Guide.
TBC Partner Site-Level 8 1 1
Interview Guide.
MTM Partner Site-Level 7 1 1
Interview Guide.
CCL Partner Site-Level 15 1 1
Informant Interview
Guide.
Cost Study Resource Use 17 1 2
and Cost Inventory
Tool--Partner/Site
Level.
----------------------------------------------------------------------------------------------------------------
Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Scientific
Integrity, Office of Science, Centers for Disease Control and
Prevention.
[FR Doc. 2020-10409 Filed 5-14-20; 8:45 am]
BILLING CODE 4163-18-P
